Literature DB >> 7772071

Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans.

C S Hanlon1, D C Rubinsztein.   

Abstract

Apolipoprotein E is a secretory glycoprotein that associates with lipoprotein particles and is coded for by a single locus on chromosome 19. The three common allelic isoforms of this protein (apo E2, apo E3 and apo E4) are associated with distinct patterns of lipoprotein metabolism and variable risks for coronary artery disease. In addition, recent work has shown that the presence of the apo E4 isoform constitutes a major risk for developing late-onset Alzheimer's disease as well as hypercholesterolaemia. The only differences between these isoforms result from cysteine-arginine interchanges at codons 112 and 158. There is considerable disagreement in the literature concerning the identity of the ancestral allele. In order to resolve this, 24 chimpanzees and individuals from a number of other primate species were analysed. All were similar to apo E4. This suggests that apo E4 is the ancestral allele and that apo E2 and apo E3 arose after the split of the human and chimpanzee lineages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772071     DOI: 10.1016/0021-9150(94)05402-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

1.  Haplotype information and linkage disequilibrium mapping for single nucleotide polymorphisms.

Authors:  Xin Lu; Tianhua Niu; Jun S Liu
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

Review 2.  Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.

Authors:  Daniel J Glass; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2011-12-03       Impact factor: 21.566

3.  Can prevalence of apolipoprotein E epsilon 4 allele explain the geographical variation of coronary heart disease mortality rates in Western Europe?

Authors:  Hong-Liang Zhang; Yi Yang; Jiang Wu
Journal:  Eur J Epidemiol       Date:  2010-09-18       Impact factor: 8.082

4.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Authors:  Chang-En Yu; Howard Seltman; Elaine R Peskind; Nichole Galloway; Peter X Zhou; Elisabeth Rosenthal; Ellen M Wijsman; Debby W Tsuang; Bernie Devlin; Gerard D Schellenberg
Journal:  Genomics       Date:  2007-04-16       Impact factor: 5.736

5.  Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL-cholesterol concentration in baboons fed an atherogenic diet.

Authors:  Amanda Vinson; Michael C Mahaney; Vince P Diego; Laura A Cox; Jeffrey Rogers; John L VandeBerg; David L Rainwater
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 6.  Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.

Authors:  Evan Dorey; Nina Chang; Qing Yan Liu; Ze Yang; Wandong Zhang
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

Review 7.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

Review 8.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

9.  Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E.

Authors:  Fotios Drenos; Thomas B L Kirkwood
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

10.  APOE Genotype Affects Cognitive Training Response in Healthy Shanghai Community-Dwelling Elderly Individuals.

Authors:  Wei Feng; Jennifer S Yokoyama; Shunying Yu; You Chen; Yan Cheng; Luke W Bonham; Dongxiang Wang; Yuan Shen; Wenyuan Wu; Chunbo Li
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.